Katherine (Katie) is currently using next generation sequencing technologies to improve understanding of how genomic testing can help improve diagnostics and patient outcomes. She previously completed a PhD in Queen’s University Belfast, UK in 2017 after which she joined RCSI. Katie is interested particularly in renal disease genomics and is currently completing a project utilizing genomic sequencing to better understand hereditary renal disease in Ireland in a collaboration with Beaumont Hospital, the National Centre for Kidney Transplantation. Katie also works as part of the Epilepsy Lighthouse Project to integrate genomic sequencing data into the electronic health records for adult and pediatric epilepsy clinics in Ireland.
Tania is interested in the genetic basis of the epilepsies, encephalitis and other neurological diseases. She completed her PhD in Medical Science (2015) and a Post-doct (2017) at the University of Campinas (UNICAMP) /Brazil, where she worked with arrays and various sequencing platforms. Within the Human Genome Variation Group, Tania is exploring rare variation across the mitochondrial genome in the context of epilepsy. She is also exploring the performance of imputation in the Brazilian population.
Rob is a graduate of DCU (BSc Genetics and Cell Biology) and NUI Maynooth (PhD Bioinformatics and Molecular Evolution) and has collaborated with Queen’s University Belfast and the University of Bristol. He is the resident bioinformatician for Professor Cavalleri's research group and is partnered with Congenica as a member of the FutureNeuro Research Centre. Rob's interests revolve around the generation and processing of next generation sequencing (NGS) data in order to address complex biological disorders. These include mapping de-novo pathogenic mutations arising in the genomes of patients with epileptic encephalopathy (severe early onset epilepsy), searching for a link between the somatic mutations occurring within the brain tissue of patients suffering from cortical dysplasia and the congenital abnormality itself, assigning human phenotype ontologies (HPO) to genetic mutations related to neurological diseases, and incorporating the Irish Electronic Patient Record (EPR) into Congenica's clinical genomics analysis software: Sapientia - with the aim of improving its diagnostic power for clinicians.
Dr Katherine Benson Postdoctoral Researcher
Katherine (Katie) is currently using next generation sequencing technologies to improve understanding of how genomic testing can help improve diagnostics and patient outcomes. She previously completed a PhD in Queen’s University Belfast, UK in 2017 after which she joined RCSI. Katie is interested particularly in renal disease genomics and is currently completing a project utilizing genomic sequencing to better understand hereditary renal disease More...
E-mail: katherinebenson@rcsi.ie Link to Profile


Dr Tania Kawasaki Postdoctoral Researcher
Tania is interested in the genetic basis of the epilepsies, encephalitis and other neurological diseases. She completed her PhD in Medical Science (2015) and a Post-doct (2017) at the University of Campinas (UNICAMP) /Brazil, where she worked with arrays and various sequencing platforms. Within the Human Genome Variation Group, Tania is exploring rare variation across the mitochondrial genome in the context of epilepsy. She is also exploring the More...
E-mail: taniakawasaki@rcsi.ie Link to Profile


Dr Robert Carton Postdoctoral Researcher
Rob is a graduate of DCU (BSc Genetics and Cell Biology) and NUI Maynooth (PhD Bioinformatics and Molecular Evolution) and has collaborated with Queen’s University Belfast and the University of Bristol. He is the resident bioinformatician for Professor Cavalleri's research group and is partnered with Congenica as a member of the FutureNeuro Research Centre. Rob's interests revolve around the generation and processing of next generation sequencing More...
E-mail: robertcarton@rcsi.ie Link to Profile